BioLineRx
BLRX
$4.38
Share price
-9.86%
Change (1 day)
256.11%
Change (1 year)
Categories
Earnings for BioLineRx (BLRX)
Earnings in 2024 (TTM): -A$23.66 Million
According to BioLineRx's latest financial reports the company's current earnings are A$21.99 Million. In 2023 the company made an earning of -A$96.72 Million a decrease over its 2022 earnings that were of -A$38.32 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for BioLineRx from 2010 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | -A$23.66 Million | -75.54% |
| 2023 | -A$96.72 Million | 152.41% |
| 2022 | -A$38.32 Million | -11.14% |
| 2021 | -A$43.12 Million | -8.69% |
| 2020 | -A$47.23 Million | 20.89% |
| 2019 | -A$39.07 Million | -7.47% |
| 2018 | -A$42.22 Million | 1.12% |
| 2017 | -A$41.75 Million | 52.84% |
| 2016 | -A$27.32 Million | 1.96% |
| 2015 | -A$26.79 Million | 0.84% |
| 2014 | -A$26.57 Million | -8.06% |
| 2013 | -A$28.9 Million | -20.91% |
| 2012 | -A$36.54 Million | |
| 2010 | A$7 M |